iPROMET: whole-body magnetic imaging as a biomarker of treatment response in prostate cancer with bone metastases

by VHIO

Results of the multi-center iPROMET study identify whole-body magnetic resonance imaging as a biomarker of response in prostate cancer patients with bone metastases. Currently, standard approaches are...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New findings for a better understanding ...

by Universitat de Barcelona

A study published in Pediatric Neurology provides a better understandi...

Photos Stream